"Dwarfism, Pituitary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of dwarfism caused by complete or partial GROWTH HORMONE deficiency, resulting from either the lack of GROWTH HORMONE-RELEASING FACTOR from the HYPOTHALAMUS or from the mutations in the growth hormone gene (GH1) in the PITUITARY GLAND. It is also known as Type I pituitary dwarfism. Human hypophysial dwarf is caused by a deficiency of HUMAN GROWTH HORMONE during development.
| Descriptor ID |
D004393
|
| MeSH Number(s) |
C05.116.099.343.445 C05.116.132.358 C10.228.140.617.738.300.300 C19.297.312 C19.700.482.311
|
| Concept/Terms |
Dwarfism, Pituitary- Dwarfism, Pituitary
- Pituitary Dwarfism
- Growth Hormone Deficiency Dwarfism
- Hyposomatotrophic Dwarfism
- Nanism, Pituitary
- Pituitary Nanism
- Isolated Growth Hormone Deficiency
- Isolated HGH Deficiency
- Isolated Human Growth Hormone Deficiency
- Isolated Somatotropin Deficiency
- Isolated Somatotropin Deficiency Disorder
- Dwarfism, Growth Hormone Deficiency
- Isolated GH Deficiency
|
Below are MeSH descriptors whose meaning is more general than "Dwarfism, Pituitary".
Below are MeSH descriptors whose meaning is more specific than "Dwarfism, Pituitary".
This graph shows the total number of publications written about "Dwarfism, Pituitary" by people in this website by year, and whether "Dwarfism, Pituitary" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2006 | 0 | 2 | 2 |
| 2007 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 0 | 2 |
| 2019 | 2 | 0 | 2 |
| 2022 | 3 | 0 | 3 |
| 2024 | 0 | 1 | 1 |
Below are the most recent publications written about "Dwarfism, Pituitary" by people in Profiles.
-
Evolving growth hormone deficiency: proof of concept. Front Endocrinol (Lausanne). 2024; 15:1398171.
-
Is GH Replacement for Adult GH Deficiency Safe? J Clin Endocrinol Metab. 2022 09 28; 107(10):e4238-e4239.
-
Safety and Efficacy of Lonapegsomatropin in Children With Growth Hormone Deficiency: enliGHten Trial 2-Year Results. J Clin Endocrinol Metab. 2022 06 16; 107(7):e2680-e2689.
-
Switching to Weekly Lonapegsomatropin from Daily Somatropin in Children with Growth Hormone Deficiency: The fliGHt Trial. Horm Res Paediatr. 2022; 95(3):233-243.
-
Circulating microRNA profile in humans and mice with congenital GH deficiency. Aging Cell. 2021 07; 20(7):e13420.
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE. Endocr Pract. 2019 Nov; 25(11):1191-1232.
-
Peak Growth Hormone Response to Combined Stimulation Test in 315 Children and Correlations with Metabolic Parameters. Horm Res Paediatr. 2019; 92(1):36-44.
-
Genetic Mutations, Birth Lengths, Weights and Head Circumferences of Children with IGF-I Receptor Defects. Comparison with other Congenital Defects in the GH/IGF-I axis. Pediatr Endocrinol Rev. 2016 Sep; 14(1):19-26.
-
Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations. Eur J Endocrinol. 2016 Jun; 174(6):C1-8.
-
Long-lived hypopituitary Ames dwarf mice are resistant to the detrimental effects of high-fat diet on metabolic function and energy expenditure. Aging Cell. 2016 06; 15(3):509-21.